ICU Medical needleless connector receives 510(k) clearance
This article was originally published in The Gray Sheet
Executive Summary
Neutron neutral-pressure needleless connector is designed to prevent all types of blood reflux in a catheter, including line and syringe disconnection, patient vascular pressure changes caused by coughing or sneezing, as well as an IV bag running dry, the firm said Aug. 3. According to ICU Medical, the neutral-pressure design may help address FDA concerns about the safety of positive displacement needleless connectors. The agency recently said it would require nine companies - including ICU - to conduct post-market surveillance studies on their connectors to determine if they are associated with higher rates of device-associated bloodstream infections (1"The Gray Sheet" Aug. 2, 2010)
You may also be interested in...
New Products In Brief
CorMatrix Cardiovascular’s ECM
Regulatory News In Brief
Hologic panel: FDA's Radiological Devices Panel will weigh in on Hologic's Selenia Dimensions 3-D digital mammography tomosynthesis system on Sept. 24 in Gaithersburg, Md. The firm is seeking PMA approval for both screening and diagnostic indications. The panel is a long time in coming: the firm backed out of a June 2009 panel review to strengthen its case for the product, which it had originally hoped to launch in 2008. The firm most recently forecast approval late this year (1"The Gray Sheet" Feb. 8, 2010). The tomosynthesis technology is designed to address what Hologic calls the primary limitation of 2-D digital mammography, "namely, the superposition of normal breast anatomy that may mask a breast cancer.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.